Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesCost-Effectiveness Analysis of Entecavir versus Lamivudine in the First-Line Treatment of Australian Patients with Chronic Hepatitis B
Applied Health Economics and Health Policy, 04/30/09
Arnold E et al. - The availability of entecavir in Australian clinical practice should make long-term suppression of hepatitis B virus replication increasingly attainable, resulting in fewer CHB sequelae, at an acceptable financial cost.
Related Articles
Entecavir for the long-term treatment of chronic hepatitis B
Expert Review of Anti-infective Therapy, 11/09/09
Relevance Score: 83%
Hepatitis B Virus Resistance to Nucleostide Analogues
Gastroenterology, 10/28/09
Relevance Score: 82%
Impact of Routine Hepatitis B Immunization on the Prevalence of Chronic Hepatitis B Virus Infection in the Marshall Islands and the Federated States of Micronesia
The Pediatric Infectious Disease Journal, 10/27/09
Relevance Score: 82%
Therapeutic vaccination and novel strategies to treat chronic HBV infection
Expert Review of Gastroenterology & Hepatology, 10/16/09
Relevance Score: 82%
Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B
Alimentary Pharmacology and Therapeutics, 11/03/09
Relevance Score: 81%
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Economic consequences of ACS-related rehospitalizations in the US
Current Medical Research and Opinion, 12/10/09
Out-of-pocket Prices of Opioid Analgesics in the United States, 1999–2004
Pain Medicine, 12/10/09
The Impact of Disposables on Project Economics in a New Antibody Plant
BioPharm, 12/09/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
Alimentary Pharmacology and Therapeutics, 12/10/09
Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection
Journal of Gastroenterology, 12/10/09
Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Repligen, 12/10/09
Sponsor
Article Search
Sponsor